Results 111 to 120 of about 59,033 (267)

Using molecular markers to assist in the selection of the rice blast resistance genes Pi1, Pi2, and Pi-ta in rice wide compatibility restorer lines

open access: yesBiotechnology & Biotechnological Equipment
Hybridization was performed between the rice materials carrying the rice blast resistance genes Pi1, Pi2, and Pi-ta (R283) as the maternal parent and the broad compatibility restorer line R110 as the paternal parent.
Hailong Yang   +8 more
doaj   +1 more source

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

open access: yesMolecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto   +8 more
wiley   +1 more source

Benchmarking Central Ohio 2008 [PDF]

open access: yes, 2008
On April 2, 2008 Benchmarking Central Ohio 2008 was released at a forum at the Columbus Metropolitan Club. The report assesses how the 8-county Columbus metropolitan area is doing, in comparison to 15 other metro areas, using a panel of 60 diverse ...

core  

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Genome Organization and Evolution of the AVR-Pita Avirulence Gene Family in the Magnaporthe grisea Species Complex

open access: yesMolecular Plant-Microbe Interactions, 2008
The avirulence (AVR) gene AVR-Pita in Magnaporthe oryzae prevents the fungus from infecting rice cultivars containing the resistance gene Pi-ta. A survey of isolates of the M.
Chang Hyun Khang   +4 more
doaj   +1 more source

System leadership for school improvement: A developing concept and set of practices [PDF]

open access: yes, 2016
System'leadership'is'a'developing'concept'and'practice'increasingly'seen'as'a' tool'for' school' improvement,' as' policy'makers' switch'from'traditional'top?down' reform' to' professional' models' of' schools' working' collaboratively.' System ...
Dimmock, Clive
core  

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

DEVELOPMENT OF SYSTEMS OF MULTIPLEX PCR TO IDENTIFY GENES OF RESISTANCE TO MAGNAPORTHE GRISEA (HERBERT) BARR. AND SELECTION OF NEW RESISTANT FORMS (DONORS) ORYZA SATIVA L. TO PATHOGEN

open access: yesЗерновое хозяйство России, 2018
Imperfect fungus Magnaporthe grisea is a phyto pathogen with a vast influence on most crops including rice. Economic damage of the disease is enormous in all rice cultivation zones of the world.
E. V. Dubina   +2 more
doaj   +2 more sources

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Home - About - Disclaimer - Privacy